HDAC9 and hypoplastic left heart syndrome: A similar effect showing elevated HDAC catalytic activity and protein expression was seen in a neonatal rodent model of hypoxia-induced RV hypertrophy, suggesting that targeting HDACs may be a promising novel therapeutic for systemic RV failure in the HLHS population.